J. M. Wolfe

2.3k total citations
22 papers, 439 citations indexed

About

J. M. Wolfe is a scholar working on Pathology and Forensic Medicine, Neurology and Genetics. According to data from OpenAlex, J. M. Wolfe has authored 22 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 8 papers in Neurology and 7 papers in Genetics. Recurrent topics in J. M. Wolfe's work include CNS Lymphoma Diagnosis and Treatment (8 papers), Lymphoma Diagnosis and Treatment (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). J. M. Wolfe is often cited by papers focused on CNS Lymphoma Diagnosis and Treatment (8 papers), Lymphoma Diagnosis and Treatment (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). J. M. Wolfe collaborates with scholars based in United States. J. M. Wolfe's co-authors include D F Moore, Vivian Jonas, Caroline Knott, Keiichi Kamisango, Lisa M. DeAngelis, Christian Grommes, Ingo K. Mellinghoff, Craig Nolan, Elena Pentsova and Thomas Kaley and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Stroke.

In The Last Decade

J. M. Wolfe

20 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. M. Wolfe United States 11 240 192 108 89 88 22 439
Bishan Dass Radotra India 12 152 0.6× 110 0.6× 152 1.4× 83 0.9× 81 0.9× 39 476
SK Shankar India 11 171 0.7× 102 0.5× 63 0.6× 21 0.2× 34 0.4× 28 355
Juan Carlos Martínez-Gutiérrez United States 15 280 1.2× 176 0.9× 53 0.5× 97 1.1× 6 0.1× 33 731
P.J. Weiller France 11 76 0.3× 35 0.2× 58 0.5× 24 0.3× 27 0.3× 53 432
France Debaugnies Belgium 11 71 0.3× 155 0.8× 35 0.3× 56 0.6× 7 0.1× 19 488
Heung Sik Kim South Korea 12 37 0.2× 82 0.4× 42 0.4× 33 0.4× 42 0.5× 59 387
Shinya Hara Japan 15 303 1.3× 262 1.4× 50 0.5× 9 0.1× 126 1.4× 45 717
Anne‐Sophie Bedin France 11 138 0.6× 89 0.5× 18 0.2× 29 0.3× 62 0.7× 17 416
Hiok Hee Chng Singapore 13 59 0.2× 125 0.7× 20 0.2× 110 1.2× 115 1.3× 25 563
Meena Shingde Australia 13 143 0.6× 62 0.3× 122 1.1× 36 0.4× 14 0.2× 22 518

Countries citing papers authored by J. M. Wolfe

Since Specialization
Citations

This map shows the geographic impact of J. M. Wolfe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. M. Wolfe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. M. Wolfe more than expected).

Fields of papers citing papers by J. M. Wolfe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. M. Wolfe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. M. Wolfe. The network helps show where J. M. Wolfe may publish in the future.

Co-authorship network of co-authors of J. M. Wolfe

This figure shows the co-authorship network connecting the top 25 collaborators of J. M. Wolfe. A scholar is included among the top collaborators of J. M. Wolfe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. M. Wolfe. J. M. Wolfe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Narayan, Azeet, J. M. Wolfe, Dennis Vu, et al.. (2024). Circulating Tumor DNA Dynamics Fail to Predict Efficacy of Poly(ADP-ribose) Polymerase/VEGFR Inhibition in Patients With Heavily Pretreated Advanced Solid Tumors. JCO Precision Oncology. 8(8). e2300289–e2300289.
2.
Yang, Zhihui, J. M. Wolfe, Kirsten A. Hirneisen, et al.. (2021). Application of whole-genome sequencing for norovirus outbreak tracking and surveillance efforts in Orange County, CA. Food Microbiology. 98. 103796–103796. 12 indexed citations
3.
Malani, Rachna, Ankush Bhatia, J. M. Wolfe, & Christian Grommes. (2019). Staging identifies non-CNS malignancies in a large cohort with newly diagnosed lymphomatous brain lesions. Leukemia & lymphoma. 60(9). 2278–2282. 17 indexed citations
4.
Navi, Babak B., Ryna Mathias, Carla Sherman, et al.. (2019). Cancer-Related Ischemic Stroke Has a Distinct Blood mRNA Expression Profile. Stroke. 50(11). 3259–3264. 17 indexed citations
5.
Grommes, Christian, J. M. Wolfe, Igor T. Gavrilovic, et al.. (2018). Phase II of Single-Agent Ibrutinib in Recurrent/Refractory Primary (PCNSL) and Secondary CNS Lymphoma (SCNSL). Blood. 132(Supplement 1). 2965–2965. 15 indexed citations
6.
Grommes, Christian, Jacqueline Stone, Craig Nolan, et al.. (2017). Phase 1B of ibrutinib and high-dose methotrexate for recurrent/refractory CNS lymphoma.. Journal of Clinical Oncology. 35(15_suppl). 7533–7533. 3 indexed citations
7.
Grommes, Christian, Igor T. Gavrilovic, Thomas Kaley, et al.. (2017). Updated results of single-agent ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL).. Journal of Clinical Oncology. 35(15_suppl). 7515–7515. 10 indexed citations
8.
Grommes, Christian, Igor T. Gavrilovic, Thomas Kaley, et al.. (2016). Phase I/II study of single agent ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL). Annals of Oncology. 27. vi105–vi105. 13 indexed citations
9.
Pentsova, Elena, et al.. (2016). Phase II study of single agent buparlisib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL). Annals of Oncology. 27. vi106–vi106. 21 indexed citations
10.
Ferguson, Donna, et al.. (2016). Enterococcusgrowth on eelgrass (Zostera marina); implications for water quality. FEMS Microbiology Ecology. 92(4). fiw047–fiw047. 9 indexed citations
11.
Grommes, Christian, Thomas Kaley, Craig Nolan, et al.. (2016). Phase I study of single agent ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL).. Journal of Clinical Oncology. 34(15_suppl). 2046–2046. 3 indexed citations
12.
Grommes, Christian, Alessandro Pastore, Igor T. Gavrilovic, et al.. (2016). Single-Agent Ibrutinib in Recurrent/Refractory Central Nervous System Lymphoma. Blood. 128(22). 783–783. 19 indexed citations
13.
Hellberg, Rosalee S., Feng Li, Rangarajan Sampath, et al.. (2014). Rapid detection and differentiation of human noroviruses using RT-PCR coupled to electrospray ionization mass spectrometry. Food Microbiology. 44. 71–80. 2 indexed citations
14.
Morris, Sheldon, D F Moore, Susan A. Wang, et al.. (2009). Strain Typing and Antimicrobial Resistance of Fluoroquinolone-ResistantNeisseria gonorrhoeaeCausing a California Infection Outbreak. Journal of Clinical Microbiology. 47(9). 2944–2949. 13 indexed citations
15.
San, Manuel, et al.. (1994). The rapid development of the glucose transport system in the excysted metacestode ofHymenolepis diminuta. Parasitology. 108(2). 217–222. 3 indexed citations
16.
Jonas, Vivian, et al.. (1993). Detection and identification of Mycobacterium tuberculosis directly from sputum sediments by amplification of rRNA. Journal of Clinical Microbiology. 31(9). 2410–2416. 205 indexed citations
17.
Wolfe, J. M. & D F Moore. (1992). Isolation of Mycobacterium thermoresistibile following augmentation mammaplasty. Journal of Clinical Microbiology. 30(4). 1036–1038. 16 indexed citations
18.
Wolfe, J. M., et al.. (1986). Mechanical responses of developing Fisher rat heart. Effects of steroid hormone.. PubMed. 8(5). 333–45. 6 indexed citations
19.
Gregory, John, et al.. (1960). Artificial Tumors in Dog Bronchus and Their Implications in Production of Experimental Emphysema.. Experimental Biology and Medicine. 105(1). 66–68. 1 indexed citations
20.
Wolfe, J. M., et al.. (1959). THE EFFECT OF ANTERIOR HYPOPHYSEAL ADMINISTRATION ON THE OVARIES OF OLD RATS1. Endocrinology. 64(5). 676–684. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bishan Dass Radotra Breakdown of academic impact, for papers by SK Shankar Breakdown of academic impact, for papers by Juan Carlos Martínez-Gutiérrez Breakdown of academic impact, for papers by P.J. Weiller Breakdown of academic impact, for papers by France Debaugnies Breakdown of academic impact, for papers by Heung Sik Kim Breakdown of academic impact, for papers by Shinya Hara Breakdown of academic impact, for papers by Anne‐Sophie Bedin Breakdown of academic impact, for papers by Hiok Hee Chng Breakdown of academic impact, for papers by Meena Shingde
Rankless by CCL
2026